Application

18626722 · Inhibitors of Mutant RET Kinases for use in Treating Cancer

Filed 2024-04-04 · Pending The official file ↗ · Art unit 1626 · Examiner Robert H Havlin Hard · CPC A61K 31/519 · Stemline Therapeutics, Inc. · McNeill PLLC

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

24.5 mo

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.